Skip to main content
Zhengye Biotechnology Holding Limited (ZYBT)
Zhengye Biotechnology Holding will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
1,250,000
Deal Size
$5.63M

ZYBT Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
46.7438.96
Depreciation & Amortization
18.816.01
Other Operating Activities
-57.21-30.67
Operating Cash Flow
17.3431.81
Operating Cash Flow Growth
-45.50%-
Other Investing Activities
-27.33-26.27
Investing Cash Flow
-27.33-26.27
Dividends Paid
-27.33-26.4
Debt Issued / Paid
34.888
Other Financing Activities
5.915.35
Financing Cash Flow
13.46-3.05
Net Cash Flow
3.462.49
Free Cash Flow
-9.995.41
Free Cash Flow Margin
-3.84%2.53%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).